155 related articles for article (PubMed ID: 10944962)
1. [The influence of thyrotoxicosis and thyroxine therapy on the risk of osteoporosis].
Zatońska K; Bolanowski M
Pol Merkur Lekarski; 2000 May; 8(47):356-9. PubMed ID: 10944962
[TBL] [Abstract][Full Text] [Related]
2. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
Sijanovic S; Karner I
Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
[TBL] [Abstract][Full Text] [Related]
3. [The risk for osteoporosis in persons treated with thyroid hormones].
Límanová Z; Stĕpán J
Vnitr Lek; 1992 Sep; 38(9):860-7. PubMed ID: 1481384
[TBL] [Abstract][Full Text] [Related]
4. Exogenous hyperthyroidism with osteoporosis.
Fallon MD; Perry HM; Bergfeld M; Droke D; Teitelbaum SL; Avioli LV
Arch Intern Med; 1983 Mar; 143(3):442-4. PubMed ID: 6830380
[TBL] [Abstract][Full Text] [Related]
5. [Bone changes in thyrotoxicosis].
Ejima E; Fujiyama K; Kiriyama T; Eguchi K
Nihon Rinsho; 1998 Jun; 56(6):1587-90. PubMed ID: 9648486
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone use and the risk of hip fracture in women > or = 65 years: a case-control study.
Van Den Eeden SK; Barzilay JI; Ettinger B; Minkoff J
J Womens Health (Larchmt); 2003; 12(1):27-31. PubMed ID: 12639366
[TBL] [Abstract][Full Text] [Related]
7. Subclinical thyroid dysfunction.
Woeber KA
Arch Intern Med; 1997 May; 157(10):1065-8. PubMed ID: 9164371
[TBL] [Abstract][Full Text] [Related]
8. [Osteoporosis treatment in patients with hyperthyroidism].
Saito J; Nishikawa T
Nihon Rinsho; 2009 May; 67(5):1011-6. PubMed ID: 19432125
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
[TBL] [Abstract][Full Text] [Related]
10. Effects of thyroxine excess on peripheral organs.
Bartalena L; Pinchera A
Acta Med Austriaca; 1994; 21(2):60-5. PubMed ID: 7998484
[TBL] [Abstract][Full Text] [Related]
11. [Thyroid and osteoporosis].
Földes J; Lakatos P
Orv Hetil; 1996 Jun; 137(25):1347-54. PubMed ID: 8757081
[TBL] [Abstract][Full Text] [Related]
12. Management of osteoporosis due to ovarian failure.
Eastell R
Med Pediatr Oncol; 2003 Sep; 41(3):222-7. PubMed ID: 12868123
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, etiology, and diagnosis of osteoporosis.
Lane NE
Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S3-11. PubMed ID: 16448873
[TBL] [Abstract][Full Text] [Related]
14. [Hormonal replacement therapy in women after surgery for thyroid cancer treated with suppressive doses of L-thyroxine].
Jastrzebska H; Gietka-Czernel M; Zgliczyński S
Wiad Lek; 2001; 54 Suppl 1():383-8. PubMed ID: 12182054
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of secondary causes that may lead to bone loss in women with osteoporosis: a retrospective study.
Odabasi E; Turan M; Tekbas F; Kutlu M
Arch Gynecol Obstet; 2009 Jun; 279(6):863-7. PubMed ID: 19020888
[TBL] [Abstract][Full Text] [Related]
16. [Osteoporosis in males].
Audran M; Legrand E; Chappard D; Bigorgne JC; Basle MF
Ann Med Interne (Paris); 2000 Sep; 151(5):399-407. PubMed ID: 11033475
[TBL] [Abstract][Full Text] [Related]
17. [Increased risk of osteoporosis in thyroid hormone substitution therapy].
Límanová Z; Stĕpán J
Cas Lek Cesk; 1990 May; 129(20):625-7. PubMed ID: 2354492
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis risk in premenopausal women.
Vondracek SF; Hansen LB; McDermott MT
Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
[TBL] [Abstract][Full Text] [Related]
19. Thyroid function and postmenopause.
Schindler AE
Gynecol Endocrinol; 2003 Feb; 17(1):79-85. PubMed ID: 12724022
[TBL] [Abstract][Full Text] [Related]
20. The lack of effect of progestogen on bone.
Lindsay R
J Reprod Med; 1999 Feb; 44(2 Suppl):215-20. PubMed ID: 11392035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
